BDTX
Price
$2.79
Change
+$0.03 (+1.09%)
Updated
Dec 12 closing price
Capitalization
158.96M
95 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$34.02
Change
+$0.46 (+1.37%)
Updated
Dec 12 closing price
Capitalization
2.98B
108 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs IDYA

Header iconBDTX vs IDYA Comparison
Open Charts BDTX vs IDYABanner chart's image
Black Diamond Therapeutics
Price$2.79
Change+$0.03 (+1.09%)
Volume$1.13M
Capitalization158.96M
IDEAYA Biosciences
Price$34.02
Change+$0.46 (+1.37%)
Volume$845.84K
Capitalization2.98B
BDTX vs IDYA Comparison Chart in %
BDTX
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDTX vs. IDYA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BDTX: $2.76 vs. IDYA: $33.56)
Brand notoriety: BDTX and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 85% vs. IDYA: 53%
Market capitalization -- BDTX: $158.96M vs. IDYA: $2.98B
BDTX [@Biotechnology] is valued at $158.96M. IDYA’s [@Biotechnology] market capitalization is $2.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 6 bearish.
  • IDYA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а +1.85% price change this week, while IDYA (@Biotechnology) price change was -6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.98B) has a higher market cap than BDTX($159M). IDYA YTD gains are higher at: 30.584 vs. BDTX (28.972). BDTX has higher annual earnings (EBITDA): 12.2M vs. IDYA (-204.84M). IDYA has more cash in the bank: 787M vs. BDTX (136M). BDTX has less debt than IDYA: BDTX (19.7M) vs IDYA (27.2M). IDYA has higher revenues than BDTX: IDYA (215M) vs BDTX (70M).
BDTXIDYABDTX / IDYA
Capitalization159M2.98B5%
EBITDA12.2M-204.84M-6%
Gain YTD28.97230.58495%
P/E Ratio7.54N/A-
Revenue70M215M33%
Total Cash136M787M17%
Total Debt19.7M27.2M72%
FUNDAMENTALS RATINGS
BDTX vs IDYA: Fundamental Ratings
BDTX
IDYA
OUTLOOK RATING
1..100
5669
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
6195
PRICE GROWTH RATING
1..100
6540
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (26) in the null industry is in the same range as BDTX (50). This means that IDYA’s stock grew similarly to BDTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (60) in the null industry is somewhat better than the same rating for BDTX (100). This means that IDYA’s stock grew somewhat faster than BDTX’s over the last 12 months.

BDTX's SMR Rating (61) in the null industry is somewhat better than the same rating for IDYA (95). This means that BDTX’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Price Growth Rating (40) in the null industry is in the same range as BDTX (65). This means that IDYA’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's P/E Growth Rating (99) in the null industry is in the same range as IDYA (100). This means that BDTX’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXIDYA
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JNOMF0.100.09
+809.09%
JUNO MINERALS LTD.
SVBT55.00N/A
N/A
SVB&T Corporation
TMOAY3.01N/A
N/A
Tomtom NV
JDHIF7.07N/A
N/A
JD HEALTH INTL INC.
CZMWF47.50-4.50
-8.65%
Carl Zeiss Meditec AG

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+3.37%
RLAY - BDTX
46%
Loosely correlated
+2.64%
CRBU - BDTX
43%
Loosely correlated
-2.11%
MLTX - BDTX
42%
Loosely correlated
-3.70%
VYGR - BDTX
39%
Loosely correlated
-0.23%
IDYA - BDTX
39%
Loosely correlated
-0.24%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.24%
NUVL - IDYA
59%
Loosely correlated
+0.16%
XENE - IDYA
59%
Loosely correlated
+0.51%
XNCR - IDYA
57%
Loosely correlated
-0.58%
IMNM - IDYA
57%
Loosely correlated
-3.99%
CGON - IDYA
56%
Loosely correlated
-0.31%
More